Department of Pathphysiology, College of Basic Medical Science, China Medical University, Shen Yang, China.
Int J Biol Sci. 2012;8(5):707-18. doi: 10.7150/ijbs.4231. Epub 2012 May 15.
Hepatic Ischemia and Reperfusion Injury (IRI) is a major cause of liver damage during liver surgery and transplantation. Ischemic preconditioning and postconditioning are strategies that can reduce IRI. In this study, different combined types of pre- and postconditioning procedures were tested in a murine warm hepatic IRI model to evaluate their protective effects. Proanthocyanidins derived from grape seed was used before ischemia process as pharmacological preconditioning to combine with technical preconditioning and postconditioning. Three pathways related to IRI, including reactive oxygen species (ROS) generation, pro-inflammatory cytokines release and hypoxia responses were examined in hepatic IRI model. Individual and combined pre- and postconditioning protocols significantly reduce liver injury by decreasing the liver ROS and cytokine levels, as well as enhancing the hypoxia tolerance response. Our data also suggested that in addition to individual preconditioning or postconditioning, the combination of these two treatments could reduce liver ischemia/reperfusion injury more effectively by increasing the activity of ROS scavengers and antioxidants. The utilization of grape seed proanthocyanidins (GSP) could improve the oxidation resistance in combined pre- and postconditioning groups. The combined protocol also further increased the liver HIF-1 alpha protein level, but had no effect on pro-inflammatory cytokines release compared to solo treatment.
肝脏缺血再灌注损伤(IRI)是肝外科手术和肝移植过程中肝损伤的主要原因。缺血预处理和后处理是可以减轻 IRI 的策略。在这项研究中,在鼠温热性肝 IRI 模型中测试了不同的预处理和后处理联合类型,以评估其保护作用。在缺血过程前使用源自葡萄籽的原花青素作为药理学预处理,与技术预处理和后处理相结合。在肝 IRI 模型中检查了与 IRI 相关的三个途径,包括活性氧(ROS)生成、促炎细胞因子释放和缺氧反应。单独和联合预处理和后处理方案通过降低肝 ROS 和细胞因子水平以及增强缺氧耐受反应显著减轻肝损伤。我们的数据还表明,除了单独的预处理或后处理之外,这两种治疗方法的联合使用可以通过增加 ROS 清除剂和抗氧化剂的活性更有效地减轻肝缺血/再灌注损伤。葡萄籽原花青素(GSP)的利用可以提高联合预处理和后处理组的抗氧化能力。与单独治疗相比,联合方案还进一步增加了肝 HIF-1α蛋白水平,但对促炎细胞因子的释放没有影响。